Masimo Co. (NASDAQ:MASI) Stock Position Reduced by Farallon Capital Management LLC

Farallon Capital Management LLC trimmed its position in Masimo Co. (NASDAQ:MASI) by 24.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,119,563 shares of the medical equipment provider’s stock after selling 370,000 shares during the quarter. Farallon Capital Management LLC owned approximately 2.11% of Masimo worth $140,998,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Dimensional Fund Advisors LP boosted its stake in Masimo by 5.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 301,488 shares of the medical equipment provider’s stock valued at $35,339,000 after purchasing an additional 16,042 shares during the period. Wells Fargo & Company MN grew its holdings in Masimo by 282.0% in the 4th quarter. Wells Fargo & Company MN now owns 116,712 shares of the medical equipment provider’s stock worth $13,680,000 after buying an additional 86,162 shares in the last quarter. Corient Private Wealth LLC increased its position in Masimo by 66.4% in the 4th quarter. Corient Private Wealth LLC now owns 4,037 shares of the medical equipment provider’s stock valued at $473,000 after acquiring an additional 1,611 shares during the period. EverSource Wealth Advisors LLC raised its stake in Masimo by 851.6% during the 4th quarter. EverSource Wealth Advisors LLC now owns 295 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 264 shares in the last quarter. Finally, Commerce Bank boosted its position in Masimo by 60.4% during the 4th quarter. Commerce Bank now owns 4,085 shares of the medical equipment provider’s stock worth $479,000 after acquiring an additional 1,539 shares during the period. 85.96% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently issued reports on MASI shares. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research note on Friday. Piper Sandler raised their target price on shares of Masimo from $160.00 to $165.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Four equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $144.67.

Masimo Trading Up 2.9 %

NASDAQ MASI opened at $125.00 on Tuesday. The firm’s 50 day moving average price is $115.33 and its two-hundred day moving average price is $124.91. The stock has a market cap of $6.65 billion, a price-to-earnings ratio of 85.03 and a beta of 0.98. Masimo Co. has a twelve month low of $75.22 and a twelve month high of $153.93. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.15 and a current ratio of 2.09.

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.77 by $0.09. Masimo had a return on equity of 14.07% and a net margin of 3.94%. The firm had revenue of $496.30 million during the quarter, compared to the consensus estimate of $493.92 million. During the same period in the prior year, the business earned $0.62 EPS. The business’s revenue for the quarter was up 9.0% on a year-over-year basis. Equities analysts anticipate that Masimo Co. will post 3.87 EPS for the current year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.